Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation
Tiantian Tang, Xueting Lang, Cong‐Fei Xu, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 307

Showing 1-25 of 307 citing articles:

The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Karen V. Swanson, Meng Deng, Jenny P.‐Y. Ting
Nature reviews. Immunology (2019) Vol. 19, Iss. 8, pp. 477-489
Open Access | Times Cited: 3550
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
Nathan Kelley, Devon Jeltema, Yanhui Duan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3328-3328
Open Access | Times Cited: 2712
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew Mangan, Edward J. Olhava, William Roush, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 8, pp. 588-606
Closed Access | Times Cited: 1547
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang Yang, Huanan Wang, Mohammed Kouadir, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 2
Open Access | Times Cited: 1063
NLRP3 inflammasome activation and cell death
Yi Huang, Wen Xu, Rongbin Zhou
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 9, pp. 2114-2127
Open Access | Times Cited: 952
Inflammasome activation and regulation: toward a better understanding of complex mechanisms
Danping Zheng, Timur Liwinski, Eran Elinav
Cell Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 724
Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
Hongbin He, Hua Jiang, Yun Chen, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 614
An update on the regulatory mechanisms of NLRP3 inflammasome activation
Seungwha Paik, Jin Kyung Kim, Prashanta Silwal, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1141-1160
Open Access | Times Cited: 533
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
Alexander Hooftman, Stefano Angiari, Svenja Hester, et al.
Cell Metabolism (2020) Vol. 32, Iss. 3, pp. 468-478.e7
Open Access | Times Cited: 429
Tranilast directly targets NLRP 3 to treat inflammasome‐driven diseases
Yi Huang, Hua Jiang, Yun Chen, et al.
EMBO Molecular Medicine (2018) Vol. 10, Iss. 4
Open Access | Times Cited: 425
Targeting the NLRP3 Inflammasome in Severe COVID-19
Tracey Freeman, Talia H. Swartz
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 390
The NLRP3 inflammasome: activation and regulation
Jie Xu, Gabriel Núñez
Trends in Biochemical Sciences (2022) Vol. 48, Iss. 4, pp. 331-344
Closed Access | Times Cited: 286
Metabolic regulation of NLRP3
Mark Hughes, Luke O'neill
Immunological Reviews (2017) Vol. 281, Iss. 1, pp. 88-98
Closed Access | Times Cited: 276
Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes
Tao Gong, Yanqing Yang, Tengchuan Jin, et al.
Trends in Immunology (2018) Vol. 39, Iss. 5, pp. 393-406
Closed Access | Times Cited: 199
Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes
Sujuan Ding, Sheng Xu, Yong Ma, et al.
Biomolecules (2019) Vol. 9, Iss. 12, pp. 850-850
Open Access | Times Cited: 191
Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases
Cong‐Fei Xu, Zi-Dong Lu, Ying‐Li Luo, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 173
Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming
Jack Green, Yu Shi, Fatima Martín‐Sánchez, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 40
Open Access | Times Cited: 167
Inflammasomes and Fibrosis
Wenjuan Zhang, Shujuan Chen, Shunchang Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 153
A new research hot spot: The role of NLRP3 inflammasome activation, a key step in pyroptosis, in diabetes and diabetic complications
Zi-Wei Yu, Jing Zhang, Xin Li, et al.
Life Sciences (2019) Vol. 240, pp. 117138-117138
Closed Access | Times Cited: 152
How location and cellular signaling combine to activate the NLRP3 inflammasome
Anil Akbal, Alesja Dernst, Marta Lovotti, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 11, pp. 1201-1214
Open Access | Times Cited: 133
Programmed cell death in atherosclerosis and vascular calcification
Min Li, Zhenwei Wang, Lijuan Fang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 130
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies
Ni Zhao, Bin Di, Lili Xu
Cytokine & Growth Factor Reviews (2021) Vol. 61, pp. 2-15
Open Access | Times Cited: 127
Loop Between NLRP3 Inflammasome and Reactive Oxygen Species
Abishai Dominic, Nhat-Tu Le, Masafumi Takahashi
Antioxidants and Redox Signaling (2021) Vol. 36, Iss. 10-12, pp. 784-796
Closed Access | Times Cited: 115
RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor
Yun Chen, Hongbin He, Bolong Lin, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 6, pp. 1425-1436
Open Access | Times Cited: 107
Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome
Hao Li, Yanling Guan, Bo Liang, et al.
European Journal of Pharmacology (2022) Vol. 928, pp. 175091-175091
Closed Access | Times Cited: 106
Page 1 - Next Page

Scroll to top